neurocare is revolutionizing mental health care
by providing innovative methods and tools based on
neurostimulation and other technologies to help clinicians deliver
personalized treatments with sustainable clinical outcomes for
patients. The investment will enable the
company to execute on its growth plans, including expansion into
the MENA region.
DUBAI, UAE, April 24, 2024 /PRNewswire/ -- TVM Capital
Healthcare, a specialist healthcare private equity firm
headquartered in Dubai and
Singapore, today announced a
US$ 17 million investment into
Munich-headquartered neurocare
group AG (neurocare), a leading innovator in personalized mental
health care, providing solutions to empower clinicians to deliver
best care to their patients. TVM Capital Healthcare's investment
will enable neurocare to execute on its international growth plans,
including expansion in the US and market entry into the
Kingdom of Saudi Arabia, as well
as support the development of new hardware and software
innovations. It is the ninth investment of TVM Capital Healthcare
to improve local access to quality healthcare in the MENA
region.
neurocare, through its digital therapy platform (DTP),
provides a holistic and patient centric treatment for a variety of
psychological or neurological conditions. It uses innovative mental
health care methods and tools including sleep assessment,
therapeutics, psychotherapy, TMS and neurofeedback, all supervised
within a cloud-based solution, to empower clinicians and deliver
individualized care. Following a detailed assessment of the
patient's condition, neurocare supports clinicians in developing
individualized therapy plans that are designed to lead to strong,
sustainable clinical outcomes. neurocare's offering is used in the
Company's own clinics in the US, Europe and Australia, as well as in a growing number of
third-party clinics.
Globally, 13.0% of people are affected by mental disorders
(WHO), causing tremendous direct and indirect costs, expected to
increase from $2.5 trillion in 2010
to $6 trillion by 2030. The number of
patients diagnosed with mental illnesses doubled during the COVID
pandemic. The treatment of mental health conditions remains
nevertheless significantly lacking in most countries, leaving a
considerable portion of the population without the necessary
support, and presenting a unique growth opportunity for companies
like neurocare offering innovative non-invasive treatments with
superior clinical outcomes.
Tristan de Boysson, Managing Partner, TVM Capital
Healthcare, stated: "This investment is part of our strategy of
investing in highly innovative, best-in-class healthcare solutions
that improve access to quality care across the globe. A special
objective of the Firm is improving the healthcare infrastructure in
Saudi Arabia and the wider MENA
Region. Most mental health clinics in this region rely on
traditional behavioural and drug care therapy methods, thus
creating a first mover advantage for companies like neurocare,
offering innovative mental health treatments with superior clinical
outcomes. We are excited about bringing this offering to the people
in the MENA Region and are looking forward to working together with
the neurocare management team to realize this objective."
Thomas Mechtersheimer, Founder and CEO of neurocare
group, added: "We are very pleased to announce the cooperation
with TVM Capital Healthcare, a strong partner with deep industry
experience. This partnership allows us to accelerate neurocare's
growth in our key markets in the US, Europe and Australia and expand our geographic footprint
into new regions. The implementation of our Digital Therapy
Platform into clinics in the MENA region represents a new milestone
in our company's growth. I want to thank all involved parties,
especially bm-t Thüringen, Aescuvest and Goerg Lawyers, for their
advice and support in closing this financing."
About TVM Capital Healthcare: TVM Capital Healthcare is
an emerging markets-focused healthcare private equity firm
headquartered in Dubai and
Singapore, with offices in
Riyadh, and Ho Chi Minh City. The Firm invests expansion
and growth capital in healthcare companies to improve local access
to quality care. Investment and operating partners as well as a
strong group of senior advisors have long-standing international
track records in healthcare investing, active board work,
contributions to strategy development and implementation, and deep
healthcare operations experience. The Firm partners with local
Middle Eastern and Southeast Asian management teams to build
domestic or regional sector champions and selectively back
companies from Europe or
North America for expansion into
the Firm's two key target geographies. TVM Capital
Healthcare's investment and operating approach combines strong
commercial value creation and returns with impact and responsible
(ESG) investing. www.tvmcapitalhealthcare.com.
About neurocare group AG: neurocare is transforming
mental health care by bringing a much-needed approach to the field:
an integrated, personalized treatment based on strong clinical
evidence. neurocare's digital therapy platform
(DTP) is the first of its kind in the area of mental
health and is empowering doctors to offer their patients the best
care for a variety of psychological or neurological
conditions. Following a detailed assessment of the patient's
condition, neurocare supports clinicians in developing
individualized therapy plans that are designed to lead to strong,
sustainable outcomes for patients, improving their self-regulation,
resilience and social skills, while being cost effective for
the healthcare system. These therapy plans integrate innovative
methods and tools, such as psychotherapy, neuromodulation and
sleep hygiene, as well as medication, to best help each
individual patient. This inclusive approach utilizing the DTP is
strongly supported by data published in leading scientific journals
which showed response rates of ~65% and >55% remission, with
very few side effects. neurocare's DTP is currently used in the
company's clinics across the US, the
Netherlands and Australia,
as well as in a growing number of third-party clinics.
www.neurocaregroup.com
Logo -
https://mma.prnewswire.com/media/2074022/TVM_Capital_Healthcare_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/tvm-capital-healthcare-announces-us-17-million-investment-into-neurocare-302124488.html